ZnO nanoparticles induce apoptosis in human dermal fibroblasts via p53 and p38 pathways.

Department of Biology and Center for Tissue Regeneration and Engineering, University of Dayton, Dayton, OH 45469, USA.
Toxicology in Vitro (Impact Factor: 3.21). 08/2011; 25(8):1721-6. DOI: 10.1016/j.tiv.2011.08.011
Source: PubMed

ABSTRACT The production of engineered nanoparticles is growing rapidly as the field of nanotechnology continues to expand. Zinc oxide nanoparticles (ZnO NPs) are used in various applications, including catalysis, electronics, biosensors, medicine, paints, sunscreens and cosmetics, thus it is important to understand the biological effects and risks of ZnO NPs. This study was designed to investigate the apoptosis induction by ZnO NPs via mitogen-activated protein kinase p38 and cell cycle checkpoint protein p53 pathways in human dermal fibroblasts. MTT-based cell viability assay showed a significant decrease in cell survivorship after ZnO NP exposure, and phase contrast images revealed that ZnO NP treated cells had lower density and a rounded morphology. Apoptosis induction was confirmed by the annexin V assay and Western blot analysis showed the up-regulation of p53 and phospho-p38 proteins. Furthermore, in ZnO NP exposed cells, p53 protein was phosphorylated at Ser33 and Ser46 sites known to be phosphorylated by p38. Our results suggest that ZnO NPs have the potential to induce apoptosis in human dermal fibroblasts via p53-p38 pathways.

  • Source
    Hark-Soo Park, Seon-Ju Kim, Taek-Jin Lee, Geon-Yong Kim, EunHo Meang, Jeong-Sup Hong, Su-Hyon Kim, Sang-Bum Koh, Seung-Guk Hong, Yle-Shik Sun, Jin Seok Kang, Yu-Ri Kim, Meyoung-Kon Kim, Jayoung Jeong, Jong-Kwon Lee, Woo-Chan Son, Jae-Hak Park
    [Show abstract] [Hide abstract]
    ABSTRACT: The study reported here was conducted to determine the systemic oral toxicity and to find the no-observed-adverse-effect level of 20 nm positively charged zinc oxide (ZnO(SM20(+))) nanoparticles in Sprague Dawley rats for 90 days. For the 90-day toxicity study, the high dose was set as 500 mg per kg of body weight (mg/kg) and the middle and low dose were set to 250 mg/kg and 125 mg/kg, respectively. The rats were held for a 14-day recovery period after the last administration, to observe for the persistence or reduction of any toxic effects. A distributional study was also carried out for the systemic distribution of ZnO(SM20(+)) NPs. No rats died during the test period. There were no significant clinical changes due to the test article during the experimental period in functional assessment, body weight, food and water consumption, ophthalmological testing, urine analysis, necropsy findings, or organ weights, but salivation was observed immediately after administration in both sexes. The total red blood cell count was increased, and hematocrit, albumin, mean cell volume, mean cell hemoglobin, and mean cell hemoglobin concentration were decreased significantly compared with control in both 500 mg/kg groups. Total protein and albumin levels were decreased significantly in both sexes in the 250 and 500 mg/kg groups. Histopathological studies revealed acinar cell apoptosis in the pancreas, inflammation and edema in stomach mucosa, and retinal atrophy of the eye in the 500 mg/kg group. There were significant parameter changes in terms of anemia in the hematological and blood chemical analyses in the 250 and 500 mg/kg groups. The significant toxic change was observed to be below 125 mg/kg, so the no-observed-adverse-effect level was not determined, but the lowest-observed-adverse-effect level was considered to be 125 mg/kg in both sexes and the target organs were found to be the pancreas, eye, and stomach.
    International Journal of Nanomedicine 01/2014; 9 Suppl 2:93-107. · 4.20 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nowadays nanoparticles have widespread application in various industries because of their special and unique features. There are many studies in side effects of nanomaterial but these studies used from high doses and specially ZnOnanoparticles in low dose was less researched. This study done by 36 Wistar rats with every other day injection of different doses of ZnOnanoparticles intraperitoneally (5, 10, 20 and 40 mg / kg). After a 21-day period, the rats were bled and whole blood hematocrit and lymphocyte numbers and serum levels of cholesterol, cortisol and testosterone hormone were measured. The results showed a significant decrease of cortisol level and significant increase of testosterone and cholesterol level of blood serum in rats that injected by ZnOnanoparticles rather than controls. Number of lymphocyte in treated rats reduced and hematocrit showed an irregular variation. Therefore all of results confirmed exposing to ZnOnanoparticles damaged to public health and reduced fertility potential.
    01/2014; 3:2277-2502.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Silicon dioxide (SiO2) and zinc oxide (ZnO) nanoparticles are widely used in various applications, raising issues regarding the possible adverse effects of these metal oxide nanoparticles on human cells. In this study, we determined the cytotoxic effects of differently charged SiO2 and ZnO nanoparticles, with mean sizes of either 100 or 20 nm, on the U373MG human glioblastoma cell line. The overall cytotoxicity of ZnO nanoparticles against U373MG cells was significantly higher than that of SiO2 nanoparticles. Neither the size nor the surface charge of the ZnO nanoparticles affected their cytotoxicity against U373MG cells. The 20 nm SiO2 nanoparticles were more toxic than the 100 nm nanoparticles against U373MG cells, but the surface charge had little or no effect on their cytotoxicity. Both SiO2 and ZnO nanoparticles activated caspase-3 and induced DNA fragmentation in U373MG cells, suggesting the induction of apoptosis. Thus, SiO2 and ZnO nanoparticles appear to exert cytotoxic effects against U373MG cells, possibly via apoptosis.
    International Journal of Nanomedicine 01/2014; 9 Suppl 2:235-41. · 4.20 Impact Factor


Available from
May 26, 2014